GSK logo

GSK Dividends Paid

Latest reported-£2.91B GBP
GSK TTM Dividends Paid · GBP (-£796.00M → -£2.91B)
High-resolution chart · PNG

GSK dividends paid history

Trailing twelve months (TTM) · GBP. Each value covers four complete reported quarters.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) Dividends Paid — Trailing twelve months (TTM) (GBP)
Period endingDividends Paid (GBP)
-2,905,500,809
-2,832,962,198
-2,801,962,198
-2,785,468,555
-2,492,000,000
-2,488,000,000
-2,596,192,192
-2,658,563,863
-2,613,563,863
-2,518,563,863
-2,353,371,671
-2,375,945,080
-2,608,455,535
-3,207,455,535
-3,604,455,535
-4,163,347,675
-4,680,431,998
-5,140,007,806
-5,134,007,806
-5,165,392,509
-4,794,797,731
-4,323,221,923
-4,318,221,923
-3,972,000,000
-3,966,000,000
-3,959,000,000
-3,953,000,000
-3,946,000,000
-3,940,000,000
-3,933,000,000
-3,927,000,000
-3,922,000,000
-3,916,000,000
-3,910,000,000
-3,906,000,000
-3,902,000,000
-3,897,000,000
-4,856,000,000
-4,850,000,000
-4,813,000,000
-4,841,000,000
-3,869,000,000
-3,874,000,000
-3,904,000,000
-3,869,000,000
-3,857,000,000
-3,843,000,000
-3,789,000,000
-3,751,000,000
-3,720,000,000
-3,680,000,000
-3,646,000,000
-3,614,000,000
-3,837,000,000
-3,814,000,000
-3,793,000,000
-3,761,000,000
-3,437,000,000
-3,406,000,000
-3,356,000,000
-3,306,000,000
-3,258,000,000
-3,205,000,000
-3,163,000,000
-3,103,000,000
-3,040,000,000
-3,007,000,000
-2,979,000,000
-2,962,000,000
-2,996,000,000
-2,974,000,000
-2,954,562,000
-2,937,562,000
-2,832,562,000
-2,795,562,000
-2,744,966,080
-2,693,966,080
-2,652,221,100
-2,597,410,240
-2,630,604,600
-2,579,604,600
-2,520,349,580
-2,475,160,440
-1,877,853,200
-2,401,853,200
-1,717,853,200
-1,146,853,200
-1,612,160,000
-1,043,160,000
-1,804,045,530
-2,330,160,000
-1,810,000,000
-1,823,000,000
-1,781,114,470
-1,800,000,000
-2,353,346,780
-2,364,346,780
-2,712,346,780
-2,330,346,780
-1,777,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.